Immunoglobulins operate by recognising specific antigens via their variable domains while utilising their constant (Fc) domains to engage immune receptors and modulate effector functions.

The global Custom Antibody Market is valued at USD 553.05 Million in 2024 and is projected to reach a value of USD 1237.1 ...

Immune checkpoint inhibitors (ICIs) are a type of immunotherapy or cancer treatment that targets specific immune cells known ...

An antibody treatment successfully prepared patients for stem cell transplants without toxic chemotherapy or radiation.

An antibody treatment developed at Stanford Medicine successfully prepared patients for stem cell transplants without toxic ...

A pioneering new study published in Nature Microbiology, led by J. Oriol Sunyer, professor of immunology and pathobiology at the School of Veterinary Medicine, and a team of researchers at Penn Vet ...

Study identifies proximity-based mechanism behind LAG-3 inhibition and introduces novel bispecific antibody for autoimmune intervention.

Chugai signed a joint research and licencing agreement with Singapore-based biotechnology firm Gero to create new antibody drug candidates ...

Researchers have developed a blood test to predict MS onset by measuring EBV antibody levels, potentially allowing early diagnosis and care.

Millions of people experience allergies annually, with about 40% of the global population having at least one allergic ...

Detailed price information for Takeda Pharmaceutical Ltd ADR (TAK-N) from The Globe and Mail including charting and trades.